PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive form of non-Hodgkin\'s lymphoma and shows extremely poor survival. This prospective pilot study to evaluate the efficacy and safety of long-acting aspargase (pegylated aspargase, PEG-ASP) combined with gemcitabine and oxaliplatin (PASP -Gemox) treatment in this population.
Epistemonikos ID: 48b5f19221c925bddc0f426c2c31f6d59e26a60e
First added on: May 11, 2024